South Korea - Export of Ambergris, Civet, Musk for Pharmaceutical Use
Since 2014, South Korea Export of Ambergris, Civet, Musk for Pharmaceutical Use was up 16.2% year on year. In 2019, the country was number 20 among other countries in Export of Ambergris, Civet, Musk for Pharmaceutical Use with $1,768,499. South Korea is overtaken by Panama, which was number 19 at $2,041,199 and is followed by Belarus with $1,549,213. Brazil lead the ranking with $63,870,803.03 in 2019, that is a decrease of 3.8% compared to 2018. United States, Spain and Colombia respectively ranked number 2, 3 and 4 in this ranking. Ireland witnessed the best average annual growth at +252.6% per year, while Thailand recorded the worst performance at -57.3% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 1,768,499.00 |
| 2018 | 1,599,318.00 |
| 2017 | 1,642,395.00 |
| 2016 | 3,264,786.00 |
| 2015 | 2,709,905.00 |
Download all data from 1988 to 2019
How does South Korea rank in Export of Ambergris, Civet, Musk for Pharmaceutical Use?
| # | 71 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Brazil
|
63,870,803.03 | 2019 | -3.8 % | +17.0 % | View data | |
| 2 |
#2
United States
|
22,744,073.61 | 2019 | -3.4 % | +4.2 % | View data | |
| 19 |
#19
Panama
|
2,041,199.00 | 2016 | NA | +43.3 % | View data | |
| 20 |
#20
South Korea
|
1,768,499.00 | 2019 | +10.6 % | +16.2 % | View data | |
| 21 |
#21
Belarus
|
1,549,213.00 | 2019 | -2.1 % | +3.4 % | View data | |